• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A False Dichotomy: Rethinking the Debate Around Pharmacotherapy vs Bariatric Metabolic Surgery in Obesity Treatment.

作者信息

Jones-Whiting Larne, Aradaib Mohammed, Mahawar Kamal

机构信息

University of Sunderland, Sunderland, UK.

出版信息

Obes Surg. 2024 Nov;34(11):3939-3940. doi: 10.1007/s11695-024-07537-2. Epub 2024 Oct 10.

DOI:10.1007/s11695-024-07537-2
PMID:39384704
Abstract
摘要

相似文献

1
A False Dichotomy: Rethinking the Debate Around Pharmacotherapy vs Bariatric Metabolic Surgery in Obesity Treatment.一种错误的二分法：重新思考肥胖治疗中药物治疗与减重代谢手术之争。
Obes Surg. 2024 Nov;34(11):3939-3940. doi: 10.1007/s11695-024-07537-2. Epub 2024 Oct 10.
2
Pharmacotherapy before and after bariatric surgery.减肥手术前后的药物治疗。
Metabolism. 2023 Nov;148:155692. doi: 10.1016/j.metabol.2023.155692. Epub 2023 Sep 18.
3
Anti-obesity Medication Use for Adolescent Metabolic and Bariatric Surgery Patients: A Systematic Literature Review.青少年代谢和减肥手术患者使用抗肥胖药物：一项系统文献综述
Cureus. 2023 Dec 21;15(12):e50905. doi: 10.7759/cureus.50905. eCollection 2023 Dec.
4
Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities.代谢和减重手术与肥胖症药物治疗预防癌症：现状与未来可能。
J Natl Cancer Inst Monogr. 2023 May 4;2023(61):68-76. doi: 10.1093/jncimonographs/lgad003.
5
Commentary on disordered eating symptoms and bariatric/metabolic surgery.对饮食失调症状和减重/代谢手术的评论。
Australas Psychiatry. 2020 Apr;28(2):153-155. doi: 10.1177/1039856219871869. Epub 2019 Sep 4.
6
Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery.接受减重手术的病态肥胖患者中未诊断及治疗不充分的2型糖尿病、高血压和血脂异常的患病率。
Obes Surg. 2014 Jun;24(6):927-35. doi: 10.1007/s11695-014-1196-z.
7
Current practices of obesity pharmacotherapy, bariatric surgery referral and coding for counselling by healthcare professionals.医疗保健专业人员在肥胖症药物治疗、减肥手术转诊及咨询编码方面的当前做法。
Obes Sci Pract. 2016 Sep;2(3):266-271. doi: 10.1002/osp4.53. Epub 2016 Jul 7.
8
Rethinking Patient and Medical Professional Perspectives on Bariatric Surgery as a Medically Necessary Treatment.重新思考患者和医疗专业人员对肥胖症手术作为一种医学必需治疗的看法。
Mayo Clin Proc. 2020 Mar;95(3):527-540. doi: 10.1016/j.mayocp.2019.09.019.
9
Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.体重减轻与生活方式治疗、药物治疗和减重手术预防和治疗 2 型糖尿病：作用机制。
Curr Obes Rep. 2015 Jun;4(2):287-302. doi: 10.1007/s13679-015-0155-x.
10
Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience.对肥胖采取积极的临床治疗方法可改善代谢和临床结局，并可避免进行减肥手术：单中心经验。
BMC Obes. 2017 Feb 21;4:9. doi: 10.1186/s40608-017-0147-3. eCollection 2017.

引用本文的文献

1
Obstacles Faced by Young Bariatric Surgeons in Greece: A Call for Change.希腊年轻减重外科医生面临的障碍：呼吁变革。
Obes Surg. 2025 May;35(5):1989-1992. doi: 10.1007/s11695-025-07820-w. Epub 2025 Mar 27.
2
Bariatric Metabolic Surgery Instead of or In Addition to Obesity Pharmacotherapy: Perspectives on the Evolving and Emerging Concept of a Medical Bypass.减重代谢手术替代肥胖药物治疗或作为其补充：关于医学旁路这一不断演变和新兴概念的观点
Obes Surg. 2025 Mar;35(3):1182-1184. doi: 10.1007/s11695-025-07704-z. Epub 2025 Jan 27.

本文引用的文献

1
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.停用司美格鲁肽后的体重反弹和心脏代谢影响：STEP 1 试验延伸。
Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. doi: 10.1111/dom.14725. Epub 2022 May 19.
2
Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences.减重手术的净货币效益增量：成本效益证据的系统评价和荟萃分析。
Obes Surg. 2021 Jul;31(7):3279-3290. doi: 10.1007/s11695-021-05415-9. Epub 2021 Apr 24.
3
GLP-1 Analogues as a Complementary Therapy in Patients after Metabolic Surgery: a Systematic Review and Qualitative Synthesis.
GLP-1 类似物作为代谢手术后患者的补充治疗：系统评价和定性综合。
Obes Surg. 2020 Sep;30(9):3561-3569. doi: 10.1007/s11695-020-04750-7. Epub 2020 Jun 5.
4
Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis.袖状胃切除术对胃饥饿素、GLP-1、PYY 和 GIP 肠激素的影响：系统评价和荟萃分析。
Ann Surg. 2020 Jul;272(1):72-80. doi: 10.1097/SLA.0000000000003614.
5
ASMBS Position Statement on medium- and long-term durability of weight loss and diabetic outcomes after conventional stapled bariatric procedures.美国代谢与减重外科学会关于传统吻合器减肥手术术后体重减轻和糖尿病结局的中长期持久性的立场声明。
Surg Obes Relat Dis. 2018 Oct;14(10):1425-1441. doi: 10.1016/j.soard.2018.08.001. Epub 2018 Aug 11.
6
Mechanisms of weight loss and improved metabolism following bariatric surgery.减重手术减肥和改善代谢的机制。
Ann N Y Acad Sci. 2018 Jan;1411(1):53-64. doi: 10.1111/nyas.13409. Epub 2017 Sep 3.
7
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.利拉鲁肽 3.0 毫克在体重管理中的随机、对照试验。
N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892.